Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $82,461,833    

Indirect Value

  $12,984,280,034      
Total Shares   142,789,105      
Total Value   $13,066,741,867      


Incyte Corp
 $32,925,824 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $318,573 Neurogene
 $16,634 Incyte Corp
 $32,925,824 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $318,573 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 16 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-23 4 B $6.95 $4,338 I/I 624 217,206 1.42 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-04 4 S $13.14 $4,363 I/I (332) 28,808 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-07-01 4 S $14.51 $4,383 I/I (302) 17,436 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2005-04-28 4 B $1.79 $4,403 I/I 2,460 4,808 1.42 -
SGEN Seagen Inc Director   –       •       •   2005-03-28 4 B $4.90 $4,415 I/I 901 270,591 2.17 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2005-04-12 4 B $3.57 $4,484 I/I 1,256 1,256 1.42 -
SGEN Seagen Inc Director   –       •       •   2005-05-04 4 B $4.79 $4,541 I/I 948 49,807 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-25 4 B $16.24 $4,581 I/I 282 193,729 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-15 4 B $7.50 $4,650 I/I 620 216,266 1.42 -
SGEN Seagen Inc Director   –       •       •   2004-08-06 4 B $5.50 $4,670 I/I 849 11,969 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-05 4 S $12.28 $4,680 I/I (381) 31,708 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2005-04-28 4 B $1.79 $4,689 I/I 2,620 5,413 1.42 -
SGEN Seagen Inc Director   –       •       •   2008-03-14 4 B $8.06 $4,707 I/I 583 365,645 2.17 -
INCY Incyte Corp Director   –       •       •   2009-03-03 4 B $2.14 $4,709 I/I 2,199 3,485,752 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-10 4 B $4.03 $4,725 I/I 1,172 1,489,174 2.17 -
INCY Incyte Corp 10% Owner   –       –       •   2003-09-22 4 B $4.89 $4,890 I/I 1,000 1,480,155 1.42 -
INCY Incyte Corp 10% Owner   –       –       •   2003-09-22 4 B $4.89 $4,890 I/I 1,000 1,091,407 1.42 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2005-04-12 4 B $3.57 $4,905 I/I 1,374 396,338 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-21 4 S $5.55 $4,980 I/I (897) 87,374 0 -
INCY Incyte Corp Director   –       •       •   2008-12-17 4 B $3.15 $4,991 I/I 1,501 135,555 2.17 -
VPHM Viropharma Inc 10% Owner   –       –       •   2005-04-28 4 B $1.79 $5,128 I/I 2,865 5,901 1.5 -
INCY Incyte Corp Director   –       •       •   2008-12-19 4 B $3.60 $5,233 I/I 1,454 285,479 2.17 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2005-04-12 4 B $3.57 $5,323 I/I 1,491 418,349 1.5 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-11-09 4 B $7.63 $5,342 I/I 700 71,099 1.5 -
SGEN Seagen Inc Director   –       •       •   2006-06-29 4 B $4.08 $5,369 I/I 1,317 85,095 2.17 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16  17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 16 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed